How to Add a Peripheral Neuropathy Program to Your Chiropractic Practice

Why Neuropathy Is the Starting Niche for Hundreds of Practices

Peripheral neuropathy is not a rare condition. More than 20 million Americans live with some form of it, burning feet, numbness in the hands, stabbing nerve pain that wakes them up at 3 a.m. Most of them have already cycled through their primary care physician, a neurologist, and a pain management specialist. The prescription? Gabapentin, Lyrica, or Cymbalta. Drugs that blunt the sensation without addressing the underlying nerve damage.

When those medications stop working, or the side effects become intolerable, patients start searching for something different. They are not looking for another referral. They are looking for a provider who will actually listen, explain what is happening in their nervous system, and offer a structured pathway toward real functional improvement.

That is the opening a well-run neuropathy program fills. There is no insurance friction because neuropathy programs are structured as cash-pay. There is no competition from the medical community because medicine has largely given up on this condition. And the patients who are ready to invest, typically middle-aged to retirement-age adults with disposable income or healthcare savings accounts, are highly motivated to pay for results.

The average program value ranges from $3,000 to $5,000 per patient. A practice running 10 to 15 new neuropathy patients per month at a $3,500 average is generating $35,000 to $52,500 in new cash revenue monthly. This is not a referral stream or an insurance upcoding opportunity. It is a standalone revenue channel built on a condition that conventional medicine cannot serve.

What a Neuropathy Program Actually Includes

A well-designed neuropathy program is not just a set of in-office treatments. The most successful versions of this model are built around four interconnected components that work together to attract patients, deliver clinical outcomes, and operate without consuming the doctor's time at every step.

• Done-for-you marketing. This includes paid social and search ads, landing pages built specifically for neuropathy patient inquiries, and automated email sequences that follow up with leads before they go cold. The marketing runs continuously in the background without the doctor writing copy or managing campaigns manually.
• Clinical protocols using FDA-cleared technologies. The treatment protocols are built around modalities with clinical evidence, devices cleared for peripheral neuropathy, nerve regeneration, and pain reduction. These protocols do not require the doctor to invent anything. They are designed to be followed by trained staff with physician oversight.
• Patient education automation. Educational modules run on autopilot, walking patients through what peripheral neuropathy is, why conventional medicine fails it, and what their treatment protocol involves. This education creates compliance, reduces cancellations, and does the heavy lifting of patient belief-building before and during care.
• A hybrid at-home model. Approximately 75% of the care in a well-structured neuropathy program happens outside the office. At-home components, devices, exercises, nutritional protocols, extend the treatment between visits, reduce the office burden, and increase patient-reported outcomes. This is what makes the economics work at scale.

The Three Reasons Neuropathy Works as a First Niche

BPA members who add multiple niche programs typically start with neuropathy. There are three structural reasons this niche outperforms others as an entry point.

1. Massive underserved patient population. With 20 million Americans affected and no satisfying medical solution, the addressable market is enormous in virtually every geographic area. A practice does not need to be in a major metro to find a steady pipeline of neuropathy patients. Small and mid-size markets are often better because there is less competition from other practices running the same program.

2. Clean cash-pay pricing with no insurance pushback. Neuropathy programs are structured outside of insurance billing. The patient pays a program fee upfront or on a structured payment plan. There are no claim denials, no prior authorizations, no clawbacks from audits. The revenue is predictable and immediate. For practices accustomed to billing insurance and waiting 60 to 90 days to collect 40 cents on the dollar, this is a fundamentally different financial model.

3. Natural cross-sells into co-occurring conditions. The patient demographics for peripheral neuropathy overlap heavily with metabolic disease, knee pain, and weight-related conditions. A neuropathy patient who is also diabetic is frequently also a metabolic program candidate. A neuropathy patient with knee degeneration from altered gait patterns may be a knee pain program candidate. Neuropathy is often the entry point into a multi-program relationship with a patient who has multiple conditions and multiple reasons to invest in their health.

What the Patient Journey Looks Like

From the first ad impression to completing the program, a well-automated neuropathy patient journey moves through a predictable sequence of touchpoints. Most of those touchpoints are handled by the system, not by the doctor or front-desk staff.

Common Mistakes Practices Make When Adding Neuropathy

Most of the practices that struggle with a neuropathy launch make the same mistakes. They are predictable, and they are avoidable.

• 1

  Building the marketing themselves

  Doctors spend months writing ads, designing landing pages, and testing email sequences. A proven system built on thousands of data points across hundreds of practices will outperform a first-time attempt at every stage. The attempt costs money, costs time, and delays revenue by months.

• 2

  Pricing too low out of fear

  Practices that are uncertain about the model often set program prices at $800 to $1,200 to "test" whether patients will pay. This creates a low-perceived-value program, attracts price-sensitive patients who churn, and generates revenues too small to justify the operational overhead. Cash-pay neuropathy patients expect and accept premium pricing.

• 3

  Doing too many in-office visits

  Some practices ignore the hybrid model and try to deliver the entire program in the office. This limits capacity, burns out staff, and makes the economics unsustainable. The at-home component is not a workaround, it is the mechanism that allows the program to scale.

• 4

  Trying to serve every neuropathy patient

  Not every neuropathy patient is a fit for a cash-pay program. Targeting the cash-pay willing segment, patients with the means and motivation to invest, dramatically improves conversion rates, outcomes, and patient satisfaction. A well-designed marketing system selects for this patient before they ever walk in the door.

What You Need to Get Started

Adding a neuropathy program to a chiropractic practice requires four things. Every practice already trying to build this from scratch is spending months discovering each requirement through trial and error. Every practice using BPA's done-for-you system has all four on day one.

1. A defined offer and pricing structure. A specific program, name, scope, duration, deliverables, and price, that can be presented clearly to a patient in a consultation. Ambiguity kills conversions. The patient needs to know exactly what they are buying and what outcome they are investing in.
2. A marketing system that generates patient inquiries. Paid ads, landing pages, and follow-up sequences that run continuously and deliver a predictable volume of qualified leads into the practice's pipeline. Marketing is not a one-time project, it is an ongoing operation that should be managed by specialists.
3. Clinical protocols backed by outcomes data. Treatment protocols built around FDA-cleared technologies and supported by clinical evidence. Not every device marketed to chiropractors has the clinical backing to justify the program price. The protocols need to deliver real results or the referral engine collapses.
4. An education system that qualifies and converts patients. Automated educational content that teaches patients about their condition, builds trust in the provider, and prepares them to make a confident enrollment decision. This is the automation that does the heavy lifting between the ad click and the consultation.

BPA provides all four components as a done-for-you system. Learn more on the full neuropathy program overview page.

How Long Before You See Revenue

The neuropathy program does not require months of build-out before it generates revenue. Most BPA member practices hold their first neuropathy seminar within their first month, and some run it in as little as two weeks. First enrollments typically follow soon after the first seminar.

The model does not require volume to be profitable. The math is straightforward.

The most important variable is not the number of patients, it is the marketing system generating a consistent pipeline. Practices that rely on sporadic seminars or word-of-mouth see inconsistent revenue. Practices running always-on digital marketing see a predictable, scalable flow of new neuropathy inquiries every month.

By month three, most practices have enough outcome data to begin generating referrals from completed program patients. Those referrals arrive pre-sold, require less marketing spend to convert, and often co-enroll in additional programs because the trust relationship is already established.

The neuropathy program is designed to be the first cash-based niche in a practice, the revenue engine that funds the infrastructure to add weight loss, metabolic health, knee pain, or other programs over time. It is built to be fast to launch, predictable in revenue, and expandable as the practice grows.